by Oleksandr Vynychuk
Nov 18, 2026 5:03 AM ET
Boston Scientific Corporation (“Boston Scientific” or “BSX”) (Ticker: BSX) (Country: US), rated A3 (negative) by Moody’s, A- (negative) by S&P, and A- (stable) by Fitch, has requested Barclays, BofA Securities, Citigroup, and J.P. Morgan to arrange four fixed income investor calls that will be held on Wednesday, November 18th. A roadshow presentation has been made available. Citigroup is coordinating logistics.
A potential offering of SEC-registered senior unsecured notes may follow, subject to market conditions, comprising USD-denominated 3-, 5-, 7- and 10-year fixed-rate notes issued by Boston Scientific and EUR-denominated 2-year floating- and fixed-rate and 4-, 8-, 12- and 20-year fixed-rate notes issued by American Medical Systems Europe B.V. and fully and unconditionally guaranteed by Boston Scientific. BofA Securities, Citigroup and J.P. Morgan have been engaged in connection with the contemplated USD offering, while Barclays, Citigroup and J.P. Morgan have been engaged in connection with the contemplated EUR offering.
Company Participants:
• Jon Monson – Executive Vice President & Chief Financial Officer
• Charlie Attlan – Senior Vice President, Strategy & Business Development, Treasurer
• Lauren Tengler – Vice President, Investor Relations
• Ali Canney – Associate Director, Capital Markets
Investor Call Schedule: Wednesday, November 18th
• 8:00am – 8:45am ET / 1:00pm – 1:45pm GMT | Registration Link: https://evercall.co/oacc/44010
• 9:00am – 9:45am ET / 2:00pm – 2:45pm GMT | Registration Link: https://evercall.co/oacc/16174
• 10:00am – 10:45am ET / 3:00pm – 3:45pm GMT | Registration Link: https://evercall.co/oacc/50204
• 1:00pm – 1:45pm ET / 6:00pm – 6:45pm GMT | Registration Link: https://evercall.co/oacc/57919
Electronic Presentation:
Direct Link: https://dealroadshow.finsight.com/e/BSX2026
URL: https://dealroadshow.finsight.com
Password: BSX2026
About Boston Scientific:
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Headquartered in Marlborough, Massachusetts, Boston Scientific develops devices used in a broad range of interventional medical specialties, including cardiovascular, endoscopy, urology and neuromodulation.